-transparent.png){kind=logo}
We have studied the induction of Epstein-Barr virus (EBV)-specific antigens in nasopharyngeal carcinoma hybrid cells by treatment with the tumor promotor 12-0-tetradecanoylphorbol-13-acetate (TPA), hydrogen peroxide (H2O2) and n-butyric acid. The intensity of EBV induction by these drugs was in the order of n-butyric acid----TPA----H2O2. Furthermore, the combination of H2O2 or TPA and n-butyric acid acted synergistically on EBV-induced antigens.
Related Publications
T Takimoto, and
H Ishiguro, and
R Umeda, and
H Ogura, and
M Hatano
January 1994,
The Laryngoscope,
T Takimoto, and
H Ishiguro, and
R Umeda, and
H Ogura, and
M Hatano
January 1985,
Auris, nasus, larynx,
T Takimoto, and
H Ishiguro, and
R Umeda, and
H Ogura, and
M Hatano
January 1984,
American journal of otolaryngology,
T Takimoto, and
H Ishiguro, and
R Umeda, and
H Ogura, and
M Hatano
August 1989,
Journal of virology,
T Takimoto, and
H Ishiguro, and
R Umeda, and
H Ogura, and
M Hatano
November 1990,
International journal of cancer,
T Takimoto, and
H Ishiguro, and
R Umeda, and
H Ogura, and
M Hatano
January 1990,
ORL; journal for oto-rhino-laryngology and its related specialties,
T Takimoto, and
H Ishiguro, and
R Umeda, and
H Ogura, and
M Hatano
May 2008,
Ai zheng = Aizheng = Chinese journal of cancer,
T Takimoto, and
H Ishiguro, and
R Umeda, and
H Ogura, and
M Hatano
March 2000,
Laboratory investigation; a journal of technical methods and pathology,
T Takimoto, and
H Ishiguro, and
R Umeda, and
H Ogura, and
M Hatano
September 1999,
International journal of cancer,
T Takimoto, and
H Ishiguro, and
R Umeda, and
H Ogura, and
M Hatano
March 1976,
Proceedings of the National Academy of Sciences of the United States of America,
